PRAXBIND

boehringer ingelheim (canada) ltd ltee🇨🇦 Health Canada

Approval Id: bbaa29beeb4f900b
Drug Approval Canada Name: PRAXBIND
Product Name: PRAXBIND
Status: Marketed
Status Date: 2016-05-24
Original Market Date: 2016-05-24
Din: 02454343
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 20:28.92
Atc Original: V03AB37 IDARUCIZIMAB
Atc Name: v 03 ab 37
Aig Number: 0158090001
Company Name: boehringer ingelheim (canada) ltd ltee
Company Address: 5180 South Service Road, Burlington, Ontario, Canada, L7L 5H4

IDARUCIZUMAB

50 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bbaa29beeb4f900b

Type

Standard